BioSpace News Archive

New requirements of the Safe Food for Canadians Regulations come into force for most businesses in the fresh fruits or vegetables sector that import, export or engage in interprovincial trade.

ECRI Institute’s Partnership for Health IT Patient Safety releases whitepaper and guide for closing the loop on diagnostic testing and referrals

New Company Advances Therapies to Address Unmet Medical Needs of Parkinson’s Disease

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, today announced that it will effect a 1-for-40 reverse stock split of its common stock, following stockholder approval of the reverse stock split at the Company’s special stockholders meeting held on January 9, 2020

INTELLiSTEM Technologies, an international biotechnology company revolutionizing cell therapy, announces today the launch of IntelliPeptidomeTM, a novel Drug Discovery Platform for rapid and systematic identification of MHC/HLA bound peptide candidates for various clinical applications.

Mercom Capital Group, llc, a global communications and research firm, released its annual report on funding and mergers and acquisitions (M&A) activity for the Digital Health / Healthcare Information Technology (IT) sector for 2019.

Independent clinical trial SMO (Site Management Organisation) Panthera Biopartners has appointed Stuart Young as chief executive. Stuart who was previously UK Country Manager of Synexus will lead the organisation’s expansion across the UK and into Europe

Technavio announced its latest market research report titled global automated microscopy market 2020-2024.

Today, HRA Pharma has announced the next phase of its international expansion into China, the second largest and most dynamic consumer healthcare (CHC) market in the world.

Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a British medical technology company that has developed a personal haemodialysis system called SC+, today announces it has entered into an agreement with B. Braun Avitum UK Ltd (“B. Braun”) to provide products and support services to Quanta’s UK patients using SC+ at home